Sign Up Today and Learn More About Apreo Health Stock
Invest in or calculate the value of your shares in Apreo Health or other pre-IPO companies through EquityZen's platform.
Apreo Health Stock
Apreo Health is developer of medical apparatus designed for diagnosing or treating respiratory, pulmonary, and lung conditions.
About Apreo Health Stock
Founded
2021
Headquarters
Menlo Park, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Apreo Health Press Mentions
Stay in the know about the latest news on Apreo Health
Anesthesia Devices Market Size to Reach USD 36.84 Billion by 2034 Driven by Technological Innovation and Growing Healthcare Demand
globenewswire • Oct 10, 2025
Cough Assist Devices Market Set to Double to USD 547.99 Million by 2034 Driven by Technological Advances and Rising Neuromuscular Disorders
globenewswire • Sep 29, 2025
Lightstone Ventures Marks Year-to-Date 2025 Milestones for its Innovative Biotech and Medtech Portfolio Companies
citybiz • Sep 25, 2025
Lightstone Ventures Marks Year-to-Date 2025 Milestones for its Innovative Biotech and Medtech Portfolio Companies
prnewswire • Sep 24, 2025
Apreo Health Raises $130 Million in Financing
mpo-mag • Aug 18, 2025
Apreo Health Management
Leadership team at Apreo Health
Co-Founder & Board Member
Hanson Gifford
Join now and verify your accreditation status to gain access to:
- Apreo Health Current Valuation
- Apreo Health Stock Price
- Apreo Health Management
- Available deals in Apreo Health and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Apreo Health Cap Table and Funding History by Share Class and Liquidity Preferences
- Apreo Health Revenue and Financials
- Apreo Health Highlights
- Apreo Health Business Model
- Apreo Health Risk Factors
- Apreo Health Research Report from SACRA Research
Trading Apreo Health Stock
How to invest in Apreo Health stock?
Accredited investors can buy pre-IPO stock in companies like Apreo Health through EquityZen funds. These investments are made available by existing Apreo Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Apreo Health stock?
Shareholders can sell their Apreo Health stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."